Viewing Study NCT05926518


Ignite Creation Date: 2025-12-25 @ 4:55 AM
Ignite Modification Date: 2026-02-02 @ 5:55 AM
Study NCT ID: NCT05926518
Status: COMPLETED
Last Update Posted: 2023-07-03
First Post: 2023-06-05
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Anti-Xa Level With Thromboprophylactic Dosage Nadroparin in Critically Ill COVID-19 and Non-COVID-19 Patients
Sponsor: Rijnstate Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Critical Illness View
None Therapeutic Drug Monitoring View
None Venous Thromboembolism View
Keywords: